全文获取类型
收费全文 | 1515篇 |
免费 | 179篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 131篇 |
妇产科学 | 24篇 |
基础医学 | 140篇 |
口腔科学 | 51篇 |
临床医学 | 206篇 |
内科学 | 376篇 |
皮肤病学 | 29篇 |
神经病学 | 60篇 |
特种医学 | 171篇 |
外科学 | 162篇 |
综合类 | 42篇 |
预防医学 | 93篇 |
眼科学 | 15篇 |
药学 | 55篇 |
中国医学 | 6篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 6篇 |
2022年 | 5篇 |
2021年 | 17篇 |
2020年 | 9篇 |
2019年 | 14篇 |
2018年 | 46篇 |
2017年 | 51篇 |
2016年 | 51篇 |
2015年 | 51篇 |
2014年 | 47篇 |
2013年 | 104篇 |
2012年 | 78篇 |
2011年 | 65篇 |
2010年 | 85篇 |
2009年 | 91篇 |
2008年 | 83篇 |
2007年 | 73篇 |
2006年 | 65篇 |
2005年 | 48篇 |
2004年 | 47篇 |
2003年 | 40篇 |
2002年 | 35篇 |
2001年 | 28篇 |
2000年 | 13篇 |
1999年 | 14篇 |
1998年 | 60篇 |
1997年 | 57篇 |
1996年 | 58篇 |
1995年 | 52篇 |
1994年 | 30篇 |
1993年 | 43篇 |
1992年 | 18篇 |
1991年 | 22篇 |
1990年 | 19篇 |
1989年 | 16篇 |
1988年 | 27篇 |
1987年 | 23篇 |
1986年 | 17篇 |
1985年 | 10篇 |
1984年 | 12篇 |
1983年 | 17篇 |
1982年 | 3篇 |
1981年 | 16篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 3篇 |
1938年 | 1篇 |
排序方式: 共有1706条查询结果,搜索用时 312 毫秒
91.
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study 总被引:15,自引:0,他引:15
Kips JC O'Connor BJ Langley SJ Woodcock A Kerstjens HA Postma DS Danzig M Cuss F Pauwels RA 《American journal of respiratory and critical care medicine》2003,167(12):1655-1659
Antagonizing the effect of interleukin (IL)-5 is a potential new treatment strategy in allergic disorders. We evaluated the safety, biological activity, and pharmacokinetics of SCH55700, a humanized anti-human IL-5 antibody, in subjects with severe persistent asthma treated with oral or high doses of inhaled steroids. In a double-blind, randomized, multicenter trial, a rising single dose of SCH55700 (0.03 mg/kg [n = 2], 0.1 mg/kg [n = 4], 0.3 mg/kg [n = 6], or 1.0 mg/kg [n = 12]) or placebo (n = 8) was administered intravenously. SCH55700 dose dependently reduced circulating eosinophil counts. At a dose of 1.0 mg/kg, the decrease remained significant up to Day 30 [(0.07 +/- 0.01) x 10(9)/L versus (0.23 +/- 0.04) x 10(9)/L at baseline] (mean +/- SEM) (p = 0.05). After administration of SCH55700 at 0.3 and 1.0 mg/kg, a trend toward improvement in baseline FEV1 was observed, which reached significance 24 hours after the 0.3-mg/kg dose (p = 0.019 versus placebo). No significant changes occurred in other clinical indices of disease activity. Adverse events were not different between active treatment and placebo. We conclude that SCH55700 is a biologically active anti-human IL-5 antibody that can be safely used in severe steroid-treated asthma. Its therapeutic potential needs to be addressed in specifically designed efficacy trials. 相似文献
92.
93.
Kölgen W Both H van Weelden H Guikers KL Bruijnzeel-Koomen CA Knol EF van Vloten WA De Gruijl FR 《The Journal of investigative dermatology》2002,118(5):812-817
Ultraviolet B radiation can suppress cellular immunity. One of the mechanisms related to this immunosuppression is the disappearance of Langerhans cells from the epidermis. The aim of this study was to establish the mechanism of ultraviolet B-induced Langerhans cell disappearance in healthy individuals. The two most likely mechanisms for Langerhans cell disappearance are apoptosis and migration. Apoptosis was assessed in vivo by exposing buttock skin of 10 healthy volunteers to six minimal erythema doses of ultraviolet B. Only very few apoptotic Langerhans cells could be observed in sections from the ultraviolet B-exposed skin. Migration of Langerhans cells cannot be established in skin sections and suction blisters were therefore raised in an attempt to trap migrating Langerhans cells in the sub-basal membrane blister fluid. Blisters were raised on the flexor side of the lower arm of 30 healthy volunteers at several time points after exposure of the skin to six minimal erythema doses of ultraviolet B. Blister fluid was collected and blister roofs were removed to check for Langerhans cell disappearance. Langerhans cells were detected in the blister fluid of the ultraviolet B-exposed skin and not of the unexposed skin. The number of Langerhans cells in the blister fluid peaked at about 18 h after ultraviolet exposure, which coincided with the largest depletion of Langerhans cells in the blister roof. A fraction (20-30%) of the Langerhans cells in the blister fluid stained positive for DNA damage (cyclobutyl pyrimidine dimers), showing that they originated from the epidermis. Ultraviolet B-induced Langerhans cell disappearance appears to be mainly attributable to migration. 相似文献
94.
大孔树脂吸附法富集野菊花总黄酮的工艺研究 总被引:11,自引:0,他引:11
目的研究大孔树脂吸附法富集野菊花总黄酮的工艺条件及参数。方法以野菊花总黄酮为考察指标,考察大孔树脂富集野菊花总黄酮的最佳工艺条件。结果野菊花提取液(50mg生药/mL)5mL上大孔树脂柱(150mm×10mm),吸附30min后,先用100mL蒸馏水洗脱除去杂质,然后用70%乙醇100mL洗脱,洗脱速度为2mg/mL,洗脱剂用量为9倍量树脂,树脂可重复使用3次,采用此条件为最佳工艺。结论AB-8型大孔树脂在所确定的工艺条件下,可较好的吸附分离野菊花总黄酮。其70%乙醇洗脱物中总黄酮质量分数达4.34%以上,总黄酮收率为84.47%以上。采用此法可以较好的富集野菊花中的有效成分。 相似文献
95.
目的探讨单核细胞向巨噬细胞分化过程中CD44 mRNA表达和黏附功能的变化。方法应用豆蔻佛波醇乙酯(PMA)诱导单核细胞系U937向巨噬细胞分化;应用RT-PCR分析U937细胞CD44 mRNA表达变化,并以β-actin作为内参进行半定量评价,并对主要条带进行测序;应用荧光染料BCECF/AM作为探针,测定黏附于激活的内皮细胞上的U937细胞数目。结果与对照组比较,PMA诱导的U937细胞CD44 mRNA总体表达显著增加(P=0.01037),异构体/标准CD44比例显著上升(P=0.0005551),测序结果显示PMA刺激后显著增加的是947 bp(V8 V9 V10)和1208 bp(V7 V8 V9 V10)CD44异构体。同时,PMA刺激后U937细胞黏附功能显著增加(P=0.0029)。结论单核细胞向巨噬细胞分化过程中CD44 mRNA,特别是947bp(V8 V9 V10)和1208 bp(V7 V8 V9 V10)CD44异构体的表达显著增加,可能与细胞黏附功能的增强相关。 相似文献
96.
MT Bardella N Molteni L Prampolini AM Giunta AR Baldassarri D Morganti PA Bianchi 《Archives of disease in childhood》1994,70(3):211-213
The use of follow up studies was evaluated in 128 patients with coeliac disease during their first visit to a department for adults. The original diagnosis had been made in childhood in all patients. Fifty eight (45%) of the subjects were following a gluten free diet, 23 (18%) were following a gluten free diet but with occasional gluten consumption, and 47 (37%) had adopted an unrestricted, gluten containing diet for a mean of 11.2 years. There was no correlation in individual subjects between the presence of symptoms, biochemical and immunological abnormalities, severity of histological findings, and the amount of dietary gluten, despite the greater frequency of symptoms in the group following an unrestricted diet than in the other two groups. Short stature and epilepsy with cerebral calcifications only occurred in patients following an unrestricted diet. As only diagnosis based on two or three biopsy samples and regular follow up correlated positively with dietary compliance, it is suggested that a histologically confirmed diagnosis of coeliac disease and regular lifelong follow up are essential in the management of these patients. 相似文献
97.
MJ Evans PA McKeever GA Pearson D Field RK Firmin 《Archives of disease in childhood》1994,71(2):F88-F92
The pathology was reviewed of the early deaths identified from the first 50 neonates treated with extracorporeal membrane oxygenation (ECMO) during its introduction to the UK. Fifteen neonates died during or shortly after ECMO between August 1989 and June 1992. Data on 12 are presented (three did not have a postmortem examination). The clinical diagnoses at referral for ECMO were as follows: persistent pulmonary hypertension of the newborn (six infants), primary congenital pneumonia (one infant), community acquired pneumonia (two infants), birth asphyxia (one infant), respiratory distress syndrome (one infant), and meconium aspiration syndrome (one infant). In our group, at necropsy, five had significant haemorrhage (three intracranial, one pulmonary, one pericardial and intraventricular). Three of five infants with evidence of haemorrhage also had signs of sepsis. Six infants had evidence at necropsy of systemic sepsis, five showed evidence of severe anoxic brain injury, and four infants had cerebellar haemorrhages. Three infants had evidence of myocardial ischaemia. It is difficult to discriminate between the relative influence of the primary diagnosis, the mode of treatment, and the severity of presentation in the genesis of this pathology. It is likely that the extent and severity of some of the findings represent a pathological progression that would have been interrupted by the death of the patient, had ECMO not been instituted. 相似文献
98.
99.
Summary Forty three patients, admitted to the department of Neurological Surgery for management of central nervous system tumours, were studied pre-operatively for serum myelin basic protein immunoreactivity as a marker of central nervous system lesion and for circulating immunoglobulins and complement (C3) levels. Myelin basic protein concentration did not appear to correlate with tumour type or grade. Serum immunoglobulin levels were found to be within the normal range but the mean IgM level was significantly higher in the glioma group when compared with meningiomas. 相似文献
100.